(Q74082735)

English

Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation

scientific article published on 01 July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

author name string

Spitzer TR

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Friedman CJ

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Bushnell W

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Frankel SR

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Raschko J

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

203-210

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918432%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702479

0 references

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute and delayed toxicities of total body irradiation. Seattle Marrow Transplant Team

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination antiemetics for cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Nutrition in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Outpatient total body irradiation for pediatric patients undergoing stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: a multicentre, double-blind, double-dummy, randomised, parallel-group study. Emesis Study Group for Ondansetron and Granisetron in Breast Ca

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702479

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74082735&oldid=1806392264"